CARD10 and lymphoma: Third, what is the role of MALT1 proteolytic activity, which is required for the survival of lymphoma cells harboring B-cell receptor or CARMA1 gain-of-function mutations, in tumors characterized by GPCR or RTK-driven CARMA3 activation?